4//SEC Filing
TZIANABOS ARTHUR 4
Accession 0001415889-24-003897
CIK 0001623526other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 4:17 PM ET
Size
7.0 KB
Accession
0001415889-24-003897
Insider Transaction Report
Form 4
TZIANABOS ARTHUR
DirectorInterim Executive Chair
Transactions
- Exercise/Conversion
Common Stock
2024-02-13$2.19/sh+31,739$69,508→ 31,739 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-13−31,739→ 0 totalExercise: $2.19Exp: 2028-12-12→ Common Stock (31,739 underlying)
Footnotes (1)
- [F1]This fully-vested option award vested as to 1/48th of the total award on October 4, 2018 with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.
Documents
Issuer
Stoke Therapeutics, Inc.
CIK 0001623526
Entity typeother
Related Parties
1- filerCIK 0001586226
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 4:17 PM ET
- Size
- 7.0 KB